Analgesics⏵
Antiandrogens⏵
Antihistamines
Azvudine
Bromhexine
Budesonide
Colchicine
Conv. Plasma
Curcumin
Famotidine
Favipiravir
Fluvoxamine
Hydroxychlor..
Ivermectin
Lifestyle⏵
Melatonin
Metformin
Minerals⏵
Molnupiravir
Monoclonals⏵
Naso/orophar..⏵
Nigella Sativa
Nitazoxanide
PPIs
Paxlovid
Quercetin
Remdesivir
Thermotherapy
Vitamins⏵
More⏵

Other
Feedback
Home
 
Top
..
Results
..
Abstract
..
All vitamin D studies
..
Meta analysis
..
Feedback
Home
←
next
study
→
previous
study
c19early.org COVID-19 treatment researchVitamin DVitamin D (more..)
Melatonin Meta
Metformin Meta
Antihistamines Meta
Azvudine Meta Molnupiravir Meta
Bromhexine Meta
Budesonide Meta
Colchicine Meta Nigella Sativa Meta
Conv. Plasma Meta Nitazoxanide Meta
Curcumin Meta PPIs Meta
Famotidine Meta Paxlovid Meta
Favipiravir Meta Quercetin Meta
Fluvoxamine Meta Remdesivir Meta
Hydroxychlor.. Meta Thermotherapy Meta
Ivermectin Meta
Home Adoption Other Treatments
@CovidAnalysis
All Studies   Meta Analysis       

Serum level of Vitamin D is associated with COVID-19 mortality rate in hospitalized patients

Ranjbar et al., Journal of Research in Medical Sciences, doi:10.4103/jrms.JRMS_1151_20
Nov 2021  
  Post
  Facebook
Share
  Source   PDF   All Studies   Meta AnalysisMeta
Mortality 42% Improvement Relative Risk Vitamin D for COVID-19  Ranjbar et al.  Sufficiency Are vitamin D levels associated with COVID-19 outcomes? Retrospective 317 patients in Iran (February - March 2020) Lower mortality with higher vitamin D levels (not stat. sig., p=0.07) c19early.org Ranjbar et al., J. Research in Medical.., Nov 2021 Favorsvitamin D Favorscontrol 0 0.5 1 1.5 2+
Vitamin D for COVID-19
8th treatment shown to reduce risk in October 2020, now with p < 0.00000000001 from 122 studies, recognized in 9 countries.
Lower risk for mortality, ICU, hospitalization, progression, recovery, cases, and viral clearance.
No treatment is 100% effective. Protocols combine treatments.
5,100+ studies for 112 treatments. c19early.org
Retrospective 317 COVID-19 hospitalized patients in Iran, showing mortality associated with lower vitamin D levels.
This is the 108th of 211 COVID-19 sufficiency studies for vitamin D, which collectively show higher levels reduce risk with p<0.0000000001 (1 in 248,027,826 vigintillion).
Important missing comments or errors? Let us know.
risk of death, 41.9% lower, RR 0.58, p = 0.07, high D levels (≥20ng/mL) 16 of 163 (9.8%), low D levels (<20ng/mL) 26 of 154 (16.9%), NNT 14.
Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates
Ranjbar et al., 29 Nov 2021, retrospective, Iran, peer-reviewed, 27 authors, study period 16 February, 2020 - 21 March, 2020.
This PaperVitamin DAll
{ 'indexed': { 'date-parts': [[2021, 12, 17]], 'date-time': '2021-12-17T21:53:43Z', 'timestamp': 1639778023175}, 'reference-count': 20, 'publisher': 'Medknow', 'issue': '1', 'content-domain': {'domain': [], 'crossmark-restriction': False}, 'short-container-title': ['J Res Med Sci'], 'published-print': {'date-parts': [[2021]]}, 'DOI': '10.4103/jrms.jrms_1151_20', 'type': 'journal-article', 'created': { 'date-parts': [[2021, 11, 29]], 'date-time': '2021-11-29T05:53:52Z', 'timestamp': 1638165232000}, 'page': '112', 'source': 'Crossref', 'is-referenced-by-count': 0, 'title': ['Serum level of Vitamin D is associated with COVID-19 mortality rate in hospitalized patients'], 'prefix': '10.4103', 'volume': '26', 'author': [ {'given': 'MahinJamshidi', 'family': 'Makiani', 'sequence': 'first', 'affiliation': []}, {'given': 'Azadeh', 'family': 'Laali', 'sequence': 'first', 'affiliation': []}, {'given': 'Mitra', 'family': 'Ranjbar', 'sequence': 'additional', 'affiliation': []}, { 'given': 'MohammadHadi', 'family': 'Karbalaie Niya', 'sequence': 'additional', 'affiliation': []}, {'given': 'Maryam', 'family': 'Roham', 'sequence': 'additional', 'affiliation': []}, {'given': 'Nader', 'family': 'Rezaie', 'sequence': 'additional', 'affiliation': []}, {'given': 'Mahdi', 'family': 'Yadollahzadeh', 'sequence': 'additional', 'affiliation': []}, {'given': 'Mohsen', 'family': 'Farrokhpour', 'sequence': 'additional', 'affiliation': []}, {'given': 'Mehdi', 'family': 'Azimi', 'sequence': 'additional', 'affiliation': []}, {'given': 'Nima', 'family': 'Motamed', 'sequence': 'additional', 'affiliation': []}, {'given': 'Dhayaneethie', 'family': 'Perumal', 'sequence': 'additional', 'affiliation': []}, { 'given': 'FahimehSafarnezhad', 'family': 'Tameshkel', 'sequence': 'additional', 'affiliation': []}, {'given': 'Farahnaz', 'family': 'Dadras', 'sequence': 'additional', 'affiliation': []}, {'given': 'NahidHashemi', 'family': 'Madani', 'sequence': 'additional', 'affiliation': []}, {'given': 'Behrooz', 'family': 'Ghanbari', 'sequence': 'additional', 'affiliation': []}, {'given': 'Amirhossein', 'family': 'Faraji', 'sequence': 'additional', 'affiliation': []}, {'given': 'Mehdi', 'family': 'Nikkhah', 'sequence': 'additional', 'affiliation': []}, {'given': 'Shahrzad', 'family': 'Rahmani', 'sequence': 'additional', 'affiliation': []}, {'given': 'Fatemah', 'family': 'Golgiri', 'sequence': 'additional', 'affiliation': []}, {'given': 'SeyedYadollah', 'family': 'Emadi', 'sequence': 'additional', 'affiliation': []}, {'given': 'Rowshanak', 'family': 'Abbasi', 'sequence': 'additional', 'affiliation': []}, {'given': 'Iman', 'family': 'Mohseni', 'sequence': 'additional', 'affiliation': []}, {'given': 'MohammadReza', 'family': 'Babaei', 'sequence': 'additional', 'affiliation': []}, {'given': 'Ramin', 'family': 'Eskandari', 'sequence': 'additional', 'affiliation': []}, {'given': 'Manizhe', 'family': 'Ataee', 'sequence': 'additional', 'affiliation': []}, {'given': 'Mahshid', 'family': 'Panahi', 'sequence': 'additional', 'affiliation': []}, {'given': 'Farhad', 'family': 'Zamani', 'sequence': 'additional', 'affiliation': []}], 'member': '2581', 'container-title': ['Journal of Research in Medical Sciences'], 'original-title': [], 'language': 'en', 'deposited': { 'date-parts': [[2021, 11, 29]], 'date-time': '2021-11-29T05:55:24Z', 'timestamp': 1638165324000}, 'score': 1, 'subtitle': [], 'short-title': [], 'issued': {'date-parts': [[2021]]}, 'references-count': 20, 'journal-issue': {'issue': '1', 'published-print': {'date-parts': [[2021]]}}, 'alternative-id': ['331348'], 'URL': 'http://dx.doi.org/10.4103/jrms.jrms_1151_20', 'relation': {}, 'ISSN': ['1735-1995'], 'issn-type': [{'value': '1735-1995', 'type': 'print'}], 'subject': ['General Medicine'], 'published': {'date-parts': [[2021]]}}
Loading..
Please send us corrections, updates, or comments. c19early involves the extraction of 100,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Treatments and other interventions are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit    
Post
Share
@CovidAnalysis
FAQ
Public domain CC0 1.0